HIGHLIGHTS
- who: Taylor T. Teague from the Department of Pulmonary and Critical Care Medicine, Mayo Clinic, First Street SW, Rochester, MN, USA have published the Article: Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis, in the Journal: (JOURNAL) of June/30,/2019
- what: Instead, this study provides significant initial insights into the clinically meaningful and patient-centric endpoints of mortality and hospitalizations.
- how: For a sensitivity analysis the authors used inverse probability treatment weighting (IPTW) instead of propensity score . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.